Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
LIFECORE BIOMEDICAL, INC.
AI Executive Summary
AI-powered analysis of 8-K filing content
Lifecore Biomedical stockholders approved the 2026 Stock Incentive Plan on June 4, 2026, authorizing up to 2.5 million shares for employee compensation. The plan becomes effective October 16, 2026, replacing the expiring 2019 plan and reflects the company's strategic shift to align employee incentives with shareholder value.
Key Takeaways
2026 Stock Incentive Plan approved by stockholders with authorization for up to 2,500,000 shares of Common Stock
Plan becomes effective October 16, 2026, and replaces the 2019 Stock Incentive Plan upon its expiration
2 more takeaways